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Background
The estimation of activity of disease in JIA patients is
difficult, and the instruments of an estimation borrowed
from adult rheumatology aren`t much useful for JIA
patients.
Objectives
To assess the correlation between disease activity scores,
using the Juvenile Arthritis Disease Activity Score
(JADAS), Disease activity score 28 (DAS 28) and Physi-
cian`s assessment of disease activity by VAS (PhGlo-
VAS) on a cohort of JIA patients including in the cross-
sectional epidemiological study in Russian Federation
(RUS).
Methods
During 3-moths cross-sectional study in 30 centers of
RUS the data of 1099 consecutive patients were col-
lected. The following key determinants of disease activ-
ity were examined: numbers of tender, swollen joints;
number of active joint and joints with patient assess-
ment of pain and global health scores (VAS); ESR; DAS
28; JADAS-71, PhGloVAS. Relationship between studied
variables was investigated using of a nonparametric
method of Spearman’s correlation analysis.
Results
There were 1099 patients with a mean age of 10.51 ±
4.54 years and the female/male ratio was 1.6. The distri-
butions of JIA patients according to ILAR cacategories
were as follows: systemic 122 (11.1%), oligoarticular 483
(43.94%), RF positive polyarthritis 81 (7.37%), RF nega-
tive polyarthritis 350 (31.84%), enthesitis-related 45
(4.09%), psoriatic 18(1.63%). The median disease
duration was 4.5±3.85 years. The mean value of JADAS-
71 score was 13.04±10.46 (95% CI 0.618), the mean
value of DAS-28 score was 3.13±1.46 (95% CI 0.08) and
mean value PhGloVAS scales was 37±24(95% CI 1.0).
The JADAS-71 correlated with PhGloVAS (r=0.8,
p<0.05) and DAS 28 (r=0.79, p<0.05). Patients have
been distributed on groups according to degree of activ-
ity depending on index DAS 28. In group with remis-
sion (DAS 28<2.6) were 445 patients (40.49%), with low
activity (DAS 28 2.6-3.2) were 208 patients (18.93%),
with moderate activity (DAS 28 3.2-5.1) were 343
patients (31.21%), with high activity (DAS 28 >5.1) were
103 patients (9.37%). In each group the correlation
between JADAS, DAS 28 was defined. The strongest
relationship was determined in patients with high activ-
ity (r=0.79-0.68, p<0.02), and the poor relationship was
in group with low activity (r=0.79-0.21, p<0.0001). In
this group (n= 208) percent of the tendered and swelled
joints which are not considered in an index DAS 28,
were 51,1% and 40,87% respectively. The greatest per-
cent of not considered involved joints was in group of
patients with a sJIA (68.9% tender joints and 71.23%
swelled). Hip, talocrural, and temporal-mandibular joints
often enough are involved at this diagnosis (18.03%,
44.26%, 2.46% respectively in our analysis) and define
functional insufficiency. As a whole, on all cohort of
patients the poor relationship between DAS and JADAS
is at patients with enthesitis-related arthritis ((r=0.79-
0.63, p<0.036).
Conclusion
JADAS and DAS 28 demonstrated strong correlation at
a high degree of activity and poor correlation at a low
degree of activity. Joints of the bottom extremities and
others aren’t considered in index DAS 28, but make
appreciable percent from total number of the involvedScientific research Institute of Rheumatology of RAMS, Moscow, Russian
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